Replay available

Moolec Science SA (MLEC) Q4 2023 Earnings Call

Moolec Science SA (NASDAQ: MLEC) Q4 2023 earnings conference call, held 2023-10-23. Replay captured from the company's public earnings webcast.

Mon, October 23, 2023 at 9:00 AMendedReplay
Moolec Science SA (MLEC) Q4 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Martin Tarasiuk

Head of Investor Relations

Gastón Palladini

Chief Executive Officer and Co-Founder

Amit Dhingra

Chief Science Officer

José López Lecube

Chief Financial Officer and Director

Replay transcript excerpt

Good morning and welcome to Mulek's conference call. My name is Martin Tarasiuk and I'm Mulek's head of investor relations. During this conference call, all participants will be muted. After management's remark, there will be a question and answer session. Please also note that today's session is being recorded. Mulek announced today its fourth quarter fiscal year 2023 business highlights. The document is now available on the company's investor relation website at ir.mulekscience.com. This morning, you will hear from Gastón Palladini, chief executive officer and co-founder of Mulek Science, together with Amit Dhingra, chief science officer, and José López Lecube, chief financial officer and director. Genk Hugenkamp, Chief Product Officer Martin Salinas, Chief of Technology and Catalina Jones, Chief of Staff and Sustainability will be joining for the Q&A. In today's call, we will refer to a presentation that will be available on the company's investor relations website. The conference call is mainly for informational purposes only and during this call, the company will be making some forward-looking statements regarding future events and results. Statements that are not historical facts including, but not limited to, statements about the company's beliefs and expectations are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Further information regarding this and other risks will be included in the company's annual report on Form 20F, filed with the SEC, later also available on our Investors Relations website. Now, I would like to turn the call over to Mulek's CEO to comment on our business and recent developments. Gaston, please go ahead. Thank you, Martin. Hello, everyone. I'm thrilled to present our annual business upd...

More from Moolec Science Sa